Rhinn; Herve
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rhinn; Herve.The latest application filed is for "anti-cd33 antibodies and methods of use thereof".
- Rhinn; Herve - San Francisco CA
- Rhinn; Herve - New York NY
- RHINN; Herve - Paris FR
- RHINN; Herve - South San Francisco CA
| Patent | Date |
|---|---|
| Anti-TMEM106B antibodies and methods of use thereof Grant 11,440,957 - Rosenthal , et al. September 13, 2 | 2022-09-13 |
| Anti-cd33 Antibodies And Methods Of Use Thereof App 20220251190 - MONROE; Kate ; et al. | 2022-08-11 |
| Gene Therapies For Lysosomal Disorders App 20220211871 - Abeliovich; Asa ; et al. | 2022-07-07 |
| Gene Therapies For Neurodegenerative Disease App 20220010001 - Abeliovich; Asa ; et al. | 2022-01-13 |
| Gene Therapies For Lysosomal Disorders App 20210332385 - ABELIOVICH; Asa ; et al. | 2021-10-28 |
| Anti-CD33 antibodies and methods of use thereof Grant 11,136,390 - Monroe , et al. October 5, 2 | 2021-10-05 |
| Gene Therapies For Neurodegenerative Diseases App 20210261981 - Abeliovich; Asa ; et al. | 2021-08-26 |
| Gene therapies for lysosomal disorders Grant 11,060,113 - Abeliovich , et al. July 13, 2 | 2021-07-13 |
| Anti-ms4a6a Antibodies And Methods Of Use Thereof App 20210122817 - KONG; Philip ; et al. | 2021-04-29 |
| Anti-ms4a4a Antibodies And Methods Of Use Thereof App 20210079074 - SUN; Jeonghoon ; et al. | 2021-03-18 |
| Anti-ms4a4a Antibodies And Methods Of Use Thereof App 20210040200 - KONG; Philip ; et al. | 2021-02-11 |
| Gene Therapies For Lysosomal Disorders App 20210010032 - ABELIOVICH; Asa ; et al. | 2021-01-14 |
| Methods Of Use Of Anti-sortilin Antibodies App 20200392229 - PAUL; Robert ; et al. | 2020-12-17 |
| Gene therapies for lysosomal disorders Grant 10,837,028 - Abeliovich , et al. November 17, 2 | 2020-11-17 |
| Anti-tmem106b Antibodies And Methods Of Use Thereof App 20200339680 - ROSENTHAL; Arnon ; et al. | 2020-10-29 |
| Gene Therapies For Lysosomal Disorders App 20200338148 - Abeliovich; Asa ; et al. | 2020-10-29 |
| Gene Therapies For Lysosomal Disorders App 20200332265 - ABELIOVICH; Asa ; et al. | 2020-10-22 |
| Gene Therapies For Lysosomal Disorders App 20200318115 - Abeliovich; Asa ; et al. | 2020-10-08 |
| Gene Therapies For Lysosomal Disorders App 20200308554 - ABELIOVICH; Asa ; et al. | 2020-10-01 |
| Gene Therapies For Neurodegenerative Diseases App 20200283800 - Abeliovich; Asa ; et al. | 2020-09-10 |
| Gene Therapies For Lysosomal Disorders App 20200282080 - Abeliovich; Asa ; et al. | 2020-09-10 |
| Gene Therapies For Lysosomal Disorders App 20200276335 - Abeliovich; Asa ; et al. | 2020-09-03 |
| Gene Therapies For Lysosomal Disorders App 20200231970 - ABELIOVICH; Asa ; et al. | 2020-07-23 |
| Gene Therapies For Lysosomal Disorders App 20200231954 - ABELIOVICH; Asa ; et al. | 2020-07-23 |
| Gene therapies for lysosomal disorders Grant 10,689,625 - Abeliovich , et al. | 2020-06-23 |
| Gene Therapies For Lysosomal Disorders App 20200071726 - ABELIOVICH; Asa ; et al. | 2020-03-05 |
| Gene Therapies For Lysosomal Disorders App 20200071680 - ABELIOVICH; Asa ; et al. | 2020-03-05 |
| Anti-cd33 Antibodies And Methods Of Use Thereof App 20190002560 - MONROE; Kate ; et al. | 2019-01-03 |
| Optimized miRNA constructs Grant 9,290,759 - Abeliovich , et al. March 22, 2 | 2016-03-22 |
| Transcriptome Wiring Analysis In Parkinson's Disease And Uses Thereof App 20140323581 - Abeliovich; Asa ; et al. | 2014-10-30 |
| OPTIMIZED miRNA CONSTRUCTS App 20140051748 - Abeliovich; Asa ; et al. | 2014-02-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 